|Articles|January 17, 2014
BioClinica, CCBR-SYNARC To Merge
BioClinica and CCBR-SYNARC have signed an agreement to merge their companies
Advertisement
BioClinica and CCBR-SYNARC have signed an agreement to merge their companies, with the combined company offering four highly specialized services to the clinical trials industry. Those services include medical imaging services across multiple therapeutic areas; worldwide network of research centers and sites; consulting services and cardiac safety monitoring services.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Articles
IQVIA and Veeva Join Forces to Improve Efficiency and Patient OutcomesSeptember 17th 2025
Managing Background Therapies in the NIMBLE Phase III TrialSeptember 17th 2025
Generative AI Transforms Clinical Study Report DevelopmentSeptember 16th 2025
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Generative AI Transforms Clinical Study Report Development
2
Why Clinical Trials Are at a Crossroads and How Site Networks Are the Key to Success
3
Atom Therapeutics Launches Global Phase II Trial of Novel Anti-Inflammatory Treatment for Acute Gout Flares
4
Merck Reports Strong Phase II Results for Ifinatamab Deruxtecan in Extensive-Stage Small Cell Lung Cancer
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
